News Release
Fourth quarter 2019 net loss was
Fourth Quarter Financial Results Highlights
-
Earnings before interest, taxes, depreciation and amortization (“EBITDA”) from ongoing operations for Aluminum Extrusions of
$14.5 million was$3.4 million lower than the fourth quarter of 2018 -
EBITDA from ongoing operations for
PE Films of$9.5 million was$3.5 million lower than the fourth quarter of 2018 -
EBITDA from ongoing operations for
Flexible Packaging Films of$4.3 million was$0.7 million higher than the fourth quarter of 2018
OPERATIONS REVIEW
Aluminum Extrusions
Aluminum Extrusions, which is also referred to as Bonnell Aluminum, produces high-quality, soft-alloy and medium-strength aluminum extrusions primarily for the following markets: building and construction, automotive, and specialty (which consists of consumer durables, machinery and equipment, electrical and distribution end-use products). A summary of fourth quarter and full year results for Aluminum Extrusions is provided below:
|
|
Three Months Ended |
|
Favorable/ |
|
Year Ended |
|
Favorable/ |
|||||||||||||
|
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
|||||||||||||
| (In thousands, except percentages) |
|
2019 |
|
2018 |
|
% Change |
|
2019 |
|
2018 |
|
% Change |
||||||||
| Sales volume (lbs) |
|
50,102 |
|
|
60,674 |
|
|
(17.4)% |
|
208,249 |
|
|
223,866 |
|
|
(7.0)% |
||||
| Net sales |
|
$ |
124,292 |
|
|
$ |
152,672 |
|
|
(18.6)% |
|
$ |
529,602 |
|
|
$ |
573,126 |
|
|
(7.6)% |
| Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
| EBITDA |
|
$ |
14,452 |
|
|
$ |
17,830 |
|
|
(18.9)% |
|
$ |
65,683 |
|
|
$ |
65,479 |
|
|
0.3% |
| Depreciation & amortization* |
|
(4,238 |
) |
|
(4,303 |
) |
|
1.5% |
|
(16,719 |
) |
|
(16,866 |
) |
|
0.9% |
||||
| EBIT** |
|
$ |
10,214 |
|
|
$ |
13,527 |
|
|
(24.5)% |
|
$ |
48,964 |
|
|
$ |
48,613 |
|
|
0.7% |
| Capital expenditures |
|
$ |
6,010 |
|
|
$ |
4,069 |
|
|
|
|
$ |
17,855 |
|
|
$ |
12,966 |
|
|
|
|
*Excludes pre-tax accelerated amortization of trade names of |
||||||||||||||||||||
|
**See the net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
||||||||||||||||||||
Fourth Quarter 2019 Results vs. Fourth Quarter 2018 Results
Net sales (sales less freight) in the fourth quarter of 2019 decreased versus 2018 primarily due to lower sales volume and the passthrough of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs. Sales volume in the fourth quarter of 2019 decreased by 17.4% versus 2018. Sales volume in the fourth quarter of 2018 was unusually strong with an increase of 20% over the fourth quarter of 2017. Sales volume in the fourth quarter of 2019 was down 1% versus the fourth quarter of 2017. Lower bookings and backlog information for Bonnell Aluminum and industry data continues to indicate softness across all key end-use markets.
EBITDA from ongoing operations in the fourth quarter of 2019 decreased by
-
Lower volumes (
$5.7 million ) and higher labor and employee-related expenses ($0.9 million ), partially offset by higher pricing ($3.5 million ) and lower die and other operating expenses ($1.2 million ); and -
A charge for inventories accounted for under the last in, first out (“LIFO”) method (
$0.5 million ) in the fourth quarter of 2019 versus a benefit in the fourth quarter of 2018 ($1.0 million ).
In
Full Year 2019 Results vs. Full Year 2018 Results
Net sales in 2019 decreased versus 2018 primarily due to lower sales volume and the passthrough of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs.
EBITDA from ongoing operations in 2019 increased slightly in comparison to 2018. Excluding the adverse impact of the accounting for inventories under the LIFO method in the fourth quarter of 2019 versus 2018 (
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Bonnell Aluminum are projected to be
|
|
|
Three Months Ended |
|
Favorable/ |
|
Year Ended |
|
Favorable/ |
||||||||||||||
|
(In thousands, except percentages) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||||||||||||
|
|
2019 |
|
2018 |
|
% Change |
|
2019 |
|
2018 |
|
% Change |
|||||||||||
|
Sales volume (lbs) |
|
26,765 |
|
|
29,064 |
|
|
(7.9 |
)% |
|
104,497 |
|
|
123,583 |
|
|
(15.4 |
)% |
||||
|
Net sales |
|
$ |
66,980 |
|
|
$ |
80,311 |
|
|
(16.6 |
)% |
|
$ |
272,758 |
|
|
$ |
332,488 |
|
|
(18.0 |
)% |
|
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
EBITDA |
|
$ |
9,456 |
|
|
$ |
12,976 |
|
|
(27.1 |
)% |
|
$ |
37,803 |
|
|
$ |
51,058 |
|
|
(26.0 |
)% |
|
Depreciation & amortization |
|
(3,885 |
) |
|
(3,652 |
) |
|
(6.4 |
)% |
|
(14,627 |
) |
|
(14,877 |
) |
|
1.7 |
% |
||||
|
EBIT* |
|
$ |
5,571 |
|
|
$ |
9,324 |
|
|
(40.3 |
)% |
|
$ |
23,176 |
|
|
$ |
36,181 |
|
|
(35.9 |
)% |
|
Capital expenditures |
|
$ |
4,424 |
|
|
$ |
8,457 |
|
|
|
|
$ |
23,920 |
|
|
$ |
21,998 |
|
|
|
||
|
* See the net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
||||||||||||||||||||||
Fourth Quarter 2019 Results vs. Fourth Quarter 2018 Results
Net sales in the fourth quarter of 2019 decreased by
Net sales in Surface Protection increased in the fourth quarter of 2019 versus the fourth quarter of 2018 due to higher volume and favorable mix, partially offset by a one-time benefit in 2018 from replacement sales associated with prior quality claims. As discussed further below, a possible customer product transition in Surface Protection continues to be delayed. Net sales decreased in Personal Care as a result of lower volume in most product categories from competitive pressures (
EBITDA from ongoing operations in the fourth quarter of 2019 decreased by
-
A
$0.3 million increase from Surface Protection, primarily due to higher volume and mix (net favorable impact of$3.3 million ) and favorable resin prices ($0.9 million ), partially offset by a one-time benefit in the fourth quarter of 2018 from replacement sales associated with prior quality claims ($2.5 million ), higher manufacturing costs ($0.5 million ) and higher selling, general and administrative costs ($0.5 million ); and -
A
$3.5 million decrease from Personal Care, primarily due to lower volume ($2.9 million ), and unfavorable mix and pricing ($1.8 million ), partially offset by lower fixed manufacturing costs ($1.3 million ).
Customer Product Transitions in Personal Care and Surface Protection
The Company previously disclosed a significant customer product transition for the Personal Care component of
Personal Care had approximately break-even EBITDA from ongoing operations in 2019 as competitive pressures resulted in missed sales and margin goals. Personal Care continues to focus on new business development and cost reduction initiatives in an effort to improve profitability.
The Surface Protection component of
The Company previously reported the risk that a portion of its film products used in surface protection applications will be made obsolete by possible future customer product transitions to less costly alternative processes or materials. These transitions principally relate to one customer. The full transition continues to encounter delays, resulting in higher than expected sales to this customer in 2019. The Company estimates that during 2020 the adverse impact on EBITDA from ongoing operations from this customer shift versus 2019 could possibly be
Full Year 2019 Results vs. Full Year 2018 Results
Net sales in 2019 decreased by
EBITDA from ongoing operations in 2019 decreased by
-
A
$6.8 million increase from Surface Protection, primarily due to higher selling prices ($6.0 million ), quality claims in 2018 that did not recur in 2019 ($1.2 million ), production efficiencies ($1.4 million ), and favorable raw material costs ($1.9 million ), partially offset by unfavorable mix (net impact of$2.0 million ) and higher fixed manufacturing and general and administrative costs ($1.5 million ); and -
A
$19.6 million decrease from Personal Care, primarily due to lower volume and unfavorable mix ($19.3 million ), unfavorable pricing ($4.8 million ), and production inefficiencies ($3.8 million ), partially offset by the timing in the passthrough of changes in resin prices ($2.1 million ), lower fixed manufacturing ($4.4 million ) and selling, general and administrative costs ($1.8 million ).
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
|
Year Ended |
|
Favorable/ (Unfavorable) % Change |
|||||||||||||||
|
(In thousands, except percentages) |
|
|
|
|
||||||||||||||||||
|
2019 |
|
2018 |
|
2019 |
|
2018 |
|
|||||||||||||||
|
Sales volume (lbs) |
25,435 |
|
|
24,718 |
|
|
2.9 |
% |
|
105,276 |
|
|
98,994 |
|
|
6.3 |
% |
|||||
|
Net sales |
$ |
31,985 |
|
|
$ |
33,364 |
|
|
(4.1 |
)% |
|
$ |
133,935 |
|
|
$ |
123,830 |
|
|
8.2 |
% |
|
|
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
EBITDA |
$ |
4,260 |
|
|
$ |
3,608 |
|
|
18.1 |
% |
|
$ |
14,737 |
|
|
$ |
11,154 |
|
|
32.1 |
% |
|
|
Depreciation & amortization |
(416 |
) |
|
(334 |
) |
|
(24.6 |
)% |
|
(1,517 |
) |
|
(1,262 |
) |
|
(20.2 |
)% |
|||||
|
EBIT* |
$ |
3,844 |
|
|
$ |
3,274 |
|
|
17.4 |
% |
|
$ |
13,220 |
|
|
$ |
9,892 |
|
|
33.6 |
% |
|
|
Capital expenditures |
$ |
3,174 |
|
|
$ |
3,109 |
|
|
|
|
$ |
8,866 |
|
|
$ |
5,423 |
|
|
|
|||
|
* See the net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
||||||||||||||||||||||
Fourth Quarter 2019 Results vs. Fourth Quarter 2018 Results
Net sales in the fourth quarter of 2019 decreased 4.1% versus the fourth quarter of 2018 primarily due to lower selling prices.
Terphane’s EBITDA from ongoing operations in the fourth quarter of 2019 increased by
-
Higher volume (
$0.3 million ) and lower fixed and variable costs ($0.2 million ), offset by lower selling prices ($0.1 million ); -
Net favorable foreign currency translation of Real-denominated operating costs (
$0.1 million ); and -
Foreign currency transaction gains of
$0.2 million in 2019 versus losses of$0.4 million in 2018.
Full Year 2019 Results vs. Full Year 2018 Results
Net sales in 2019 increased versus 2018 primarily due to higher sales volume and increased selling prices.
Terphane’s EBITDA from ongoing operations in 2019 increased by
-
Higher volume (
$2.6 million ) and higher selling prices ($1.6 million ), partially offset by higher fixed and variable costs, including costs related to a restarted line ($2.0 million ); -
Net favorable foreign currency translation of Real-denominated operating costs of
$0.4 million ; and -
Foreign currency transaction gains of
$1.0 million in 2019 versus losses of$0.8 million in 2018.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
Corporate Expenses, Investments, Interest and Taxes
Pension expense was
Interest expense was
During 2019, the Company recognized consolidated income tax expense of
Tredegar’s approximately 18% ownership in kaleo, Inc. (“kaléo”), which is accounted for under the fair value method, was estimated at a value of
CAPITAL STRUCTURE
Total debt was
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When we use the words “believe,” “estimate,” “anticipate,” “expect,” “project,” “plan”, “likely,” “may” and similar expressions, we do so to identify forward-looking statements. Such statements are based on our then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ from expectations include, without limitation, the following:
- loss or gain of sales to significant customers on which our business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
- failure of our customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
-
risks of doing business in countries outside the
U.S. that affect our substantial international operations; - political, economic, and regulatory factors concerning our products;
- uncertain economic conditions in countries in which we do business;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
- a change in the amount of our underfunded defined benefit (pension) plan liability;
- an increase in the operating costs incurred by our operating companies, including, for example, the cost of raw materials and energy;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- disruption to our manufacturing facilities;
- the impact of public health epidemics on our employees, our production and the global economy, such as the coronavirus currently impacting a number of countries;
- an information technology system failure or breach;
- volatility and uncertainty of the valuation of our investment in kaléo;
- the impact of the imposition of tariffs and sanctions on imported aluminum ingot used in our aluminum extrusions;
-
the impact of new tariffs or duties imposed as a result of rising trade tensions between the
U.S. and other countries; - failure to establish and maintain effective internal control over financial reporting;
-
the termination of anti-dumping duties on products imported to
Brazil that compete with products produced byFlexible Packaging Films ;
and the other factors discussed in the reports
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
|
|
||||||||||||||||
|
Condensed Consolidated Statements of Income |
||||||||||||||||
|
(In Thousands, Except Per-Share Data) |
||||||||||||||||
|
(Unaudited) |
||||||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
2019 |
|
2018 |
|
2019 |
|
2018 |
||||||||
|
Sales |
|
$ |
232,427 |
|
|
$ |
275,707 |
|
|
$ |
972,358 |
|
|
$ |
1,065,471 |
|
|
Other income (expense), net (c) (e) |
|
(45 |
) |
|
18,927 |
|
|
34,795 |
|
|
30,459 |
|
||||
|
|
|
232,382 |
|
|
294,634 |
|
|
1,007,153 |
|
|
1,095,930 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cost of goods sold (c) |
|
182,711 |
|
|
218,521 |
|
|
767,511 |
|
|
849,756 |
|
||||
|
Freight |
|
9,170 |
|
|
9,360 |
|
|
36,063 |
|
|
36,027 |
|
||||
|
Selling, R&D and general expenses (c) |
|
30,105 |
|
|
26,432 |
|
|
113,988 |
|
|
103,990 |
|
||||
|
Amortization of identifiable intangibles (f) |
|
8,419 |
|
|
900 |
|
|
13,601 |
|
|
3,976 |
|
||||
|
Pension and postretirement benefits |
|
2,396 |
|
|
2,597 |
|
|
9,642 |
|
|
10,406 |
|
||||
|
Interest expense |
|
697 |
|
|
1,163 |
|
|
4,051 |
|
|
5,702 |
|
||||
|
Asset impairments and costs associated with exit and disposal activities (c) |
|
530 |
|
|
1,113 |
|
|
4,125 |
|
|
2,913 |
|
||||
|
|
|
— |
|
|
— |
|
|
— |
|
|
46,792 |
|
||||
|
|
|
234,028 |
|
|
260,086 |
|
|
948,981 |
|
|
1,059,562 |
|
||||
|
Income (loss) before income taxes |
|
(1,646 |
) |
|
34,548 |
|
|
58,172 |
|
|
36,368 |
|
||||
|
Income tax expense (benefit) (g) |
|
1,489 |
|
|
8,391 |
|
|
9,913 |
|
|
11,526 |
|
||||
|
Net income (loss) |
|
$ |
(3,135 |
) |
|
$ |
26,157 |
|
|
$ |
48,259 |
|
|
$ |
24,842 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
|
$ |
(0.09 |
) |
|
$ |
0.79 |
|
|
$ |
1.45 |
|
|
$ |
0.75 |
|
|
Diluted |
|
$ |
(0.09 |
) |
|
$ |
0.79 |
|
|
$ |
1.45 |
|
|
$ |
0.75 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Shares used to compute earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
|
33,278 |
|
|
33,103 |
|
|
33,236 |
|
|
33,068 |
|
||||
|
Diluted |
|
33,278 |
|
|
33,112 |
|
|
33,258 |
|
|
33,092 |
|
||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
(In Thousands) |
||||||||||||||||
|
(Unaudited) |
||||||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
2019 |
|
2018 |
|
2019 |
|
2018 |
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Aluminum Extrusions |
|
$ |
124,292 |
|
|
$ |
152,672 |
|
|
$ |
529,602 |
|
|
$ |
573,126 |
|
|
|
|
66,980 |
|
|
80,311 |
|
|
272,758 |
|
|
332,488 |
|
||||
|
|
|
31,985 |
|
|
33,364 |
|
|
133,935 |
|
|
123,830 |
|
||||
|
Total net sales |
|
223,257 |
|
|
266,347 |
|
|
936,295 |
|
|
1,029,444 |
|
||||
|
Add back freight |
|
9,170 |
|
|
9,360 |
|
|
36,063 |
|
|
36,027 |
|
||||
|
Sales as shown in the Condensed Consolidated Statements of Income |
|
$ |
232,427 |
|
|
$ |
275,707 |
|
|
$ |
972,358 |
|
|
$ |
1,065,471 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Aluminum Extrusions: |
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
|
EBITDA (b) |
|
$ |
14,452 |
|
|
$ |
17,830 |
|
|
$ |
65,683 |
|
|
$ |
65,479 |
|
|
Depreciation & amortization |
|
(4,238 |
) |
|
(4,303 |
) |
|
(16,719 |
) |
|
(16,866 |
) |
||||
|
EBIT (b) |
|
10,214 |
|
|
13,527 |
|
|
48,964 |
|
|
48,613 |
|
||||
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
106 |
|
|
(109 |
) |
|
(561 |
) |
|
(505 |
) |
||||
|
Trade name accelerated amortization (f) |
|
(7,530 |
) |
|
— |
|
|
(10,040 |
) |
|
— |
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
|
EBITDA (b) |
|
9,456 |
|
|
12,976 |
|
|
37,803 |
|
|
51,058 |
|
||||
|
Depreciation & amortization |
|
(3,885 |
) |
|
(3,652 |
) |
|
(14,627 |
) |
|
(14,877 |
) |
||||
|
EBIT (b) |
|
5,571 |
|
|
9,324 |
|
|
23,176 |
|
|
36,181 |
|
||||
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
(1,408 |
) |
|
(1,363 |
) |
|
(475 |
) |
|
(5,905 |
) |
||||
|
|
|
— |
|
|
— |
|
|
— |
|
|
(46,792 |
) |
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
|
EBITDA (b) |
|
4,260 |
|
|
3,608 |
|
|
14,737 |
|
|
11,154 |
|
||||
|
Depreciation & amortization |
|
(416 |
) |
|
(334 |
) |
|
(1,517 |
) |
|
(1,262 |
) |
||||
|
EBIT (b) |
|
3,844 |
|
|
3,274 |
|
|
13,220 |
|
|
9,892 |
|
||||
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
— |
|
|
(45 |
) |
|
— |
|
|
(45 |
) |
||||
|
|
|
10,797 |
|
|
24,608 |
|
|
74,284 |
|
|
41,439 |
|
||||
|
Interest income |
|
133 |
|
|
79 |
|
|
296 |
|
|
369 |
|
||||
|
Interest expense |
|
697 |
|
|
1,163 |
|
|
4,051 |
|
|
5,702 |
|
||||
|
Gain on investment in kaléo accounted for under fair value method (e) |
|
— |
|
|
18,700 |
|
|
28,482 |
|
|
30,600 |
|
||||
|
Loss on sale of investment property |
|
— |
|
|
(38 |
) |
|
— |
|
|
(38 |
) |
||||
|
Unrealized loss on investment property |
|
— |
|
|
— |
|
|
— |
|
|
(186 |
) |
||||
|
Stock option-based compensation costs (c) |
|
2,088 |
|
|
415 |
|
|
4,209 |
|
|
1,221 |
|
||||
|
Corporate expenses, net (c) |
|
9,791 |
|
|
7,223 |
|
|
36,630 |
|
|
28,893 |
|
||||
|
Income (loss) before income taxes |
|
(1,646 |
) |
|
34,548 |
|
|
58,172 |
|
|
36,368 |
|
||||
|
Income tax expense (benefit) (g) |
|
1,489 |
|
|
8,391 |
|
|
9,913 |
|
|
11,526 |
|
||||
|
Net income (loss) |
|
$ |
(3,135 |
) |
|
$ |
26,157 |
|
|
$ |
48,259 |
|
|
$ |
24,842 |
|
|
|
||||||
|
Condensed Consolidated Balance Sheets |
||||||
|
(In Thousands) |
||||||
|
(Unaudited) |
||||||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
Assets |
|
|
|
|
||
|
Cash & cash equivalents |
|
$ |
31,422 |
|
$ |
34,397 |
|
Accounts & other receivables, net |
|
107,558 |
|
124,727 |
||
|
Income taxes recoverable |
|
4,100 |
|
6,783 |
||
|
Inventories |
|
81,380 |
|
93,810 |
||
|
Prepaid expenses & other |
|
8,696 |
|
9,564 |
||
|
Total current assets |
|
233,156 |
|
269,281 |
||
|
Property, plant & equipment, net |
|
242,890 |
|
228,369 |
||
|
Right-of-use leased assets |
|
19,220 |
|
— |
||
|
Investment in kaléo (cost basis of |
|
95,500 |
|
84,600 |
||
|
Identifiable intangible assets, net |
|
22,636 |
|
36,295 |
||
|
|
|
81,404 |
|
81,404 |
||
|
Deferred income taxes |
|
13,129 |
|
3,412 |
||
|
Other assets |
|
4,733 |
|
4,012 |
||
|
Total assets |
|
$ |
712,668 |
|
$ |
707,373 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
||
|
Accounts payable |
|
$ |
103,657 |
|
$ |
112,758 |
|
Accrued expenses |
|
45,809 |
|
42,495 |
||
|
Lease liability, short-term |
|
3,002 |
|
— |
||
|
Total current liabilities |
|
152,468 |
|
155,253 |
||
|
Lease liability, long-term |
|
17,689 |
|
— |
||
|
Long-term debt |
|
42,000 |
|
101,500 |
||
|
Pension and other postretirement benefit obligations, net |
|
107,446 |
|
88,124 |
||
|
Deferred income taxes |
|
11,019 |
|
— |
||
|
Other noncurrent liabilities |
|
5,297 |
|
7,639 |
||
|
Shareholders’ equity |
|
376,749 |
|
354,857 |
||
|
Total liabilities and shareholders’ equity |
|
$ |
712,668 |
|
$ |
707,373 |
|
|
||||||||
|
Condensed Consolidated Statements of Cash Flows |
||||||||
|
(In Thousands) |
||||||||
|
(Unaudited) |
||||||||
|
|
|
|
||||||
|
|
|
Year Ended |
||||||
|
|
|
2019 |
|
2018 |
||||
|
Cash flows from operating activities: |
|
|
|
|
||||
|
Net income |
|
$ |
48,259 |
|
|
$ |
24,842 |
|
|
Adjustments for noncash items: |
|
|
|
|
||||
|
Depreciation |
|
30,683 |
|
|
29,828 |
|
||
|
Amortization of intangibles |
|
13,601 |
|
|
3,976 |
|
||
|
Reduction of right-of-use assets |
|
2,588 |
|
|
— |
|
||
|
|
|
— |
|
|
46,792 |
|
||
|
Deferred income taxes |
|
5,856 |
|
|
8,626 |
|
||
|
Accrued pension and postretirement benefits |
|
9,642 |
|
|
10,406 |
|
||
|
(Gain) loss on investment in kaléo accounted for under the fair value method |
|
(10,900 |
) |
|
(30,600 |
) |
||
|
Loss on asset impairments |
|
519 |
|
|
223 |
|
||
|
(Gain) loss on sale of assets |
|
(6,334 |
) |
|
(46 |
) |
||
|
Changes in assets and liabilities: |
|
|
|
|
||||
|
Accounts and other receivables |
|
16,471 |
|
|
(11,883 |
) |
||
|
Inventories |
|
11,315 |
|
|
(9,577 |
) |
||
|
Income taxes recoverable/payable |
|
2,644 |
|
|
25,018 |
|
||
|
Prepaid expenses and other |
|
795 |
|
|
(1,924 |
) |
||
|
Accounts payable and accrued expenses |
|
(2,937 |
) |
|
5,571 |
|
||
|
Lease liability |
|
(2,723 |
) |
|
— |
|
||
|
Pension and postretirement benefit plan contributions |
|
(8,614 |
) |
|
(8,907 |
) |
||
|
Other, net |
|
4,998 |
|
|
5,449 |
|
||
|
Net cash provided by operating activities |
|
115,863 |
|
|
97,794 |
|
||
|
Cash flows from investing activities: |
|
|
|
|
||||
|
Capital expenditures |
|
(50,864 |
) |
|
(40,814 |
) |
||
|
Return of escrowed funds relating to acquisition earn-out |
|
— |
|
|
4,250 |
|
||
|
Net proceeds from sale of investment property |
|
— |
|
|
1,384 |
|
||
|
Proceeds from the sale of assets and other |
|
10,936 |
|
|
1,098 |
|
||
|
Net cash used in investing activities |
|
(39,928 |
) |
|
(34,082 |
) |
||
|
Cash flows from financing activities: |
|
|
|
|
||||
|
Borrowings |
|
65,500 |
|
|
76,750 |
|
||
|
Debt principal payments |
|
(125,000 |
) |
|
(127,250 |
) |
||
|
Dividends paid |
|
(15,325 |
) |
|
(14,592 |
) |
||
|
Debt financing costs |
|
(1,817 |
) |
|
— |
|
||
|
Repurchase of employee common stock for tax withholdings |
|
(854 |
) |
|
(328 |
) |
||
|
Proceeds from exercise of stock options and other |
|
184 |
|
|
1,332 |
|
||
|
Net cash used in financing activities |
|
(77,312 |
) |
|
(64,088 |
) |
||
|
Effect of exchange rate changes on cash |
|
(1,598 |
) |
|
(1,718 |
) |
||
|
Increase (decrease) in cash and cash equivalents |
|
(2,975 |
) |
|
(2,094 |
) |
||
|
Cash and cash equivalents at beginning of period |
|
34,397 |
|
|
36,491 |
|
||
|
Cash and cash equivalents at end of period |
|
$ |
31,422 |
|
|
$ |
34,397 |
|
|
|
Notes to the Financial Tables |
|
|
|
(Unaudited) |
|
|
|
|
|
|
(a) |
Tredegar’s presentation of net income from ongoing operations and earnings per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which have been presented separately and removed from net income and diluted earnings per share as reported under GAAP. Net income from ongoing operations and earnings per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income or earnings per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income from ongoing operations and earnings per share from ongoing operations for the three months and the years ended |
|
(In millions, except per share data) |
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
|
|
2019 |
|
2018 |
|
2019 |
|
2018 |
||||||||
|
Net income (loss) as reported under GAAP |
|
$ |
(3.1 |
) |
|
$ |
26.2 |
|
|
$ |
48.3 |
|
|
$ |
24.8 |
|
|
After-tax effects of: |
|
|
|
|
|
|
|
|
||||||||
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.9 |
|
|
1.2 |
|
|
(1.3 |
) |
|
3.8 |
|
||||
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
|
(Gain) loss associated with the investment in kaléo |
|
— |
|
|
(14.7 |
) |
|
(23.4 |
) |
|
(23.9 |
) |
||||
|
Accelerated trade name amortization |
|
5.8 |
|
|
— |
|
|
7.8 |
|
|
— |
|
||||
|
Other |
|
3.6 |
|
|
1.5 |
|
|
6.2 |
|
|
4.4 |
|
||||
|
|
|
— |
|
|
— |
|
|
— |
|
|
38.2 |
|
||||
|
Net income from ongoing operations |
|
$ |
7.2 |
|
|
$ |
14.2 |
|
|
$ |
37.6 |
|
|
$ |
47.3 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings (loss) per share as reported under GAAP (diluted) |
|
(0.09 |
) |
|
0.79 |
|
|
1.45 |
|
|
0.75 |
|
||||
|
After-tax effects per diluted share of: |
|
|
|
|
|
|
|
|
||||||||
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.03 |
|
|
0.04 |
|
|
(0.04 |
) |
|
0.12 |
|
||||
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
|
(Gain) loss associated with the investment in kaléo |
|
— |
|
|
(0.44 |
) |
|
(0.70 |
) |
|
(0.72 |
) |
||||
|
Accelerated trade name amortization |
|
0.17 |
|
|
— |
|
|
0.23 |
|
|
— |
|
||||
|
Other |
|
0.11 |
|
|
0.04 |
|
|
0.19 |
|
|
0.13 |
|
||||
|
|
|
— |
|
|
— |
|
|
— |
|
|
1.15 |
|
||||
|
Earnings per share from ongoing operations (diluted) |
|
0.22 |
|
|
0.43 |
|
|
1.13 |
|
|
1.43 |
|
||||
|
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (h). |
||
|
(b) |
In the fourth quarter of 2019, the Company changed its segment measure of profit and loss from operating profit from ongoing operations to EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations. EBITDA from ongoing operations is the key profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. For more business segment information, see Note 5 in the Notes to Financial Statements in the 2019 Form 10-K. |
|
|
|
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income as defined by GAAP. EBIT is a widely understood and utilized metric that is meaningful to certain investors. We believe that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations. |
|
|
|
|
|
|
(c) |
Losses associated with plant shutdowns, asset impairments, restructurings and other items for continuing operations for the three months and the years ended |
|
|
(in millions) |
Three Months Ended
|
|
Year Ended
|
||||||||||||||
|
|
Pre-Tax |
|
Net of Tax |
|
Pre-Tax |
|
Net of Tax |
||||||||||
|
Aluminum Extrusions: |
|
|
|
|
|
||||||||||||
|
(Gains)/losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|
||||||||||||
|
Wind damage to roof of |
$ |
(0.4 |
) |
$ |
(0.3 |
) |
|
$ |
(0.1 |
) |
$ |
(0.1 |
) |
||||
|
Environmental charges at |
0.2 |
|
0.2 |
|
|
0.6 |
|
0.5 |
|
||||||||
|
Total for Aluminum Extrusions |
$ |
(0.2 |
) |
$ |
(0.1 |
) |
|
$ |
0.5 |
|
$ |
0.4 |
|
||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
(Gains)/losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
Asset-related expenses |
$ |
0.1 |
|
$ |
0.1 |
|
|
$ |
0.7 |
|
$ |
0.7 |
|
||||
|
Gain from sale of plant3 |
— |
|
— |
|
|
(6.3 |
) |
(5.9 |
) |
||||||||
|
Employee-related expenses |
— |
|
— |
|
|
0.1 |
|
0.1 |
|
||||||||
|
Consolidation of Personal Care manufacturing facilities - |
|
|
|
|
|
||||||||||||
|
Severance |
— |
|
— |
|
|
0.6 |
|
0.4 |
|
||||||||
|
Asset impairment |
— |
|
— |
|
|
0.1 |
|
0.1 |
|
||||||||
|
Product qualifications1 |
— |
|
— |
|
|
0.1 |
|
0.1 |
|
||||||||
|
|
|
|
|
|
|
||||||||||||
|
Severance |
0.2 |
|
0.1 |
|
|
0.9 |
|
0.7 |
|
||||||||
|
Asset impairment |
— |
|
— |
|
|
0.2 |
|
0.2 |
|
||||||||
|
Safety/quality initiative1 |
0.1 |
|
0.1 |
|
|
0.1 |
|
0.1 |
|
||||||||
|
Accelerated depreciation1 |
0.4 |
|
0.3 |
|
|
1.2 |
|
0.9 |
|
||||||||
|
Product qualifications1 |
0.1 |
|
0.1 |
|
|
0.3 |
|
0.2 |
|
||||||||
|
Reserve for inventory impairment - Personal Care's |
— |
|
— |
|
|
0.2 |
|
0.1 |
|
||||||||
|
Other restructuring costs - severance |
0.2 |
|
0.2 |
|
|
0.8 |
|
0.7 |
|
||||||||
|
Write-off Personal Care production line - |
— |
|
— |
|
|
0.4 |
|
0.3 |
|
||||||||
|
Subtotal for |
1.2 |
|
0.9 |
|
|
(0.6 |
) |
(1.3 |
) |
||||||||
|
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|
||||||||||||
|
Estimated excess costs associated with ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects1 |
0.3 |
|
0.2 |
|
|
1.0 |
|
0.8 |
|
||||||||
|
Total for |
$ |
1.4 |
|
$ |
1.1 |
|
|
$ |
0.4 |
|
$ |
(0.5 |
) |
||||
|
|
|
|
|
|
|
||||||||||||
|
Corporate: |
|
|
|
|
|
||||||||||||
|
Professional fees associated with: internal control over financial reporting; business development activities; and implementation of new accounting guidance2 |
$ |
0.8 |
|
$ |
0.6 |
|
|
$ |
5.2 |
|
$ |
4.0 |
|
||||
|
Accelerated recognition of stock option-based compensation5 |
1.3 |
|
1.2 |
|
|
1.3 |
|
1.2 |
|
||||||||
|
Environmental costs not associated with a business unit2 |
0.6 |
|
0.5 |
|
|
0.6 |
|
0.5 |
|
||||||||
|
Total for Corporate |
$ |
2.7 |
|
$ |
2.3 |
|
|
$ |
7.1 |
|
$ |
5.7 |
|
||||
|
1. Included in “Cost of goods sold” in the condensed consolidated statements of income. |
|||||||||||||||||
|
2. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. |
|||||||||||||||||
|
3. Included in “Other income (expense), net” in the condensed consolidated statements of income. |
|||||||||||||||||
|
4. Additional information on costs associated with exit and disposal activities and other details are available in Note 17 of the 2019 Form 10-K. |
|||||||||||||||||
|
5. Included in “Stock option-based compensation costs” in the net sales and EBITDA from ongoing operations by segment statements. |
|||||||||||||||||
|
|
Three Months Ended
|
|
|
Year Ended
|
|||||||||||||
|
(in millions) |
Pre-Tax |
|
Net of Tax |
|
|
Pre-Tax |
|
Net of Tax |
|||||||||
|
Aluminum Extrusions: |
|
|
|
|
|
||||||||||||
|
Losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
|
||||||||||||
|
Other restructuring costs - severance |
$ |
— |
|
$ |
— |
|
|
$ |
0.1 |
|
$ |
0.1 |
|
||||
|
|
|
|
|
|
|
||||||||||||
|
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|
||||||||||||
|
Wind damage to roof of |
— |
|
— |
|
|
0.1 |
|
0.1 |
|
||||||||
|
Environmental charges at |
0.1 |
|
0.1 |
|
|
0.3 |
|
0.2 |
|
||||||||
|
Subtotal for Aluminum Extrusions |
0.1 |
|
0.1 |
|
|
0.4 |
|
0.3 |
|
||||||||
|
Total for Aluminum Extrusions |
$ |
0.1 |
|
$ |
0.1 |
|
|
$ |
0.5 |
|
$ |
0.4 |
|
||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
Losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
Asset-related expenses |
$ |
0.3 |
|
$ |
0.3 |
|
|
$ |
0.3 |
|
$ |
0.3 |
|
||||
|
Severance & employee-related expenses |
0.4 |
|
0.4 |
|
|
1.8 |
|
1.8 |
|
||||||||
|
Severance & employee-related expenses - administrative1 |
0.1 |
|
0.1 |
|
|
0.4 |
|
0.4 |
|
||||||||
|
Accelerated depreciation1 |
0.1 |
|
0.1 |
|
|
0.6 |
|
0.6 |
|
||||||||
|
Other restructuring costs - severance |
0.3 |
|
0.3 |
|
|
0.7 |
|
0.5 |
|
||||||||
|
Subtotal for |
1.2 |
|
1.2 |
|
|
3.8 |
|
3.6 |
|
||||||||
|
|
|
|
|
|
|
||||||||||||
|
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|
||||||||||||
|
Estimated excess costs associated with ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects1 |
0.3 |
|
0.2 |
|
|
2.0 |
|
1.7 |
|
||||||||
|
Costs related to a fire that occurred at a facility in Retsag, |
0.1 |
|
0.1 |
|
|
0.1 |
|
0.1 |
|
||||||||
|
Costs to prepare a market study2 |
— |
|
— |
|
|
0.2 |
|
0.1 |
|
||||||||
|
Gain on reversal of contingent liability3 |
(0.3 |
) |
(0.2 |
) |
|
(0.3 |
) |
(0.2 |
) |
||||||||
|
Subtotal for |
0.1 |
|
0.1 |
|
|
2.0 |
|
1.7 |
|
||||||||
|
Total for |
$ |
1.3 |
|
$ |
1.3 |
|
|
$ |
5.8 |
|
$ |
5.3 |
|
||||
|
|
|
|
|
|
|
||||||||||||
|
Corporate: |
|
|
|
|
|
||||||||||||
|
Professional fees associated with: internal control over financial reporting; business development activities; and implementation of new accounting guidance2 |
$ |
0.6 |
|
$ |
0.5 |
|
|
$ |
1.1 |
|
$ |
0.9 |
|
||||
|
Loss on investment in |
0.1 |
|
0.1 |
|
|
0.5 |
|
0.4 |
|
||||||||
|
Business development projects2 |
0.5 |
|
0.4 |
|
|
0.5 |
|
0.4 |
|
||||||||
|
Total for Corporate |
$ |
1.2 |
|
$ |
1.0 |
|
|
$ |
2.1 |
|
$ |
1.7 |
|
||||
|
1. Included in “Cost of goods sold” in the condensed consolidated statements of income. |
|||||||||||||||||
|
2. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. |
|||||||||||||||||
|
3. Included in “Other income (expense), net” in the condensed consolidated statements of income. |
|||||||||||||||||
|
(d) |
|
|
|
|
||
|
(e) |
A pre-tax gain on the Company’s investment in kaleo, Inc. (“kaléo”) of |
|
|
(f) |
On |
|
|
(in millions) |
Three Months Ended |
|||||
|
|
|
|
|
|||
|
|
$ |
1.2 |
$ |
3.6 |
||
|
Futura - accelerated |
1.3 |
3.9 |
||||
|
Futura - ongoing1 |
0.1 |
0.1 |
||||
|
Total amortization |
$ |
2.6 |
$ |
7.6 |
||
|
1. Amortization based on original useful life. |
||||||
|
(g) |
Net debt is calculated as follows: |
|
(in millions) |
|
|
|
|
||
|
Debt |
|
$ |
42.0 |
|
$ |
101.5 |
|
Less: Cash and cash equivalents |
|
31.4 |
|
34.4 |
||
|
Net debt |
|
$ |
10.6 |
|
$ |
67.1 |
|
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes. |
||
|
|
|
|
|
(h) |
Tredegar’s presentation of net income (loss) from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which have been presented separately and removed from net income (loss) and diluted earnings (loss) per share as reported under GAAP. Net income (loss) from ongoing operations is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) or earnings (loss) per share as defined by GAAP. It excludes items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three and twelve months ended |
|
(In millions) |
Pre-Tax |
|
Taxes Expense (Benefit) |
|
After-Tax |
|
Effective Tax Rate |
||||||||
|
Three Months Ended |
(a) |
|
(b) |
|
|
|
(b)/(a) |
||||||||
|
Net income (loss) reported under GAAP |
$ |
(1.6 |
) |
|
$ |
1.5 |
|
|
$ |
(3.1 |
) |
|
(90.5 |
)% |
|
|
Losses associated with plant shutdowns, asset impairments and restructurings |
1.2 |
|
|
0.3 |
|
|
0.9 |
|
|
|
|||||
|
(Gains) losses from sale of assets and other |
10.6 |
|
|
1.2 |
|
|
9.4 |
|
|
|
|||||
|
Net income (loss) from ongoing operations |
$ |
10.2 |
|
|
$ |
3.0 |
|
|
$ |
7.2 |
|
|
28.4 |
% |
|
|
Three Months Ended |
|
|
|
|
|
|
|
||||||||
|
Net income (loss) reported under GAAP |
$ |
34.5 |
|
|
$ |
— |
|
|
$ |
26.2 |
|
|
24.3 |
% |
|
|
Losses associated with plant shutdowns, asset impairments and restructurings |
1.3 |
|
|
0.1 |
|
|
1.2 |
|
|
|
|||||
|
(Gains) losses from sale of assets and other |
(17.2 |
) |
|
(4.0 |
) |
|
(13.2 |
) |
|
|
|||||
|
Net income (loss) from ongoing operations |
$ |
18.6 |
|
|
$ |
(3.9 |
) |
|
$ |
14.2 |
|
|
24.9 |
% |
|
|
Twelve Months Ended |
|
|
|
|
|
|
|
||||||||
|
Net income (loss) reported under GAAP |
$ |
58.2 |
|
|
$ |
9.9 |
|
|
$ |
48.3 |
|
|
17.0 |
% |
|
|
Losses associated with plant shutdowns, asset impairments and restructurings |
(0.5 |
) |
|
0.8 |
|
|
(1.3 |
) |
|
|
|||||
|
(Gains) losses from sale of assets and other |
(9.5 |
) |
|
(0.1 |
) |
|
(9.4 |
) |
|
|
|||||
|
Net income (loss) from ongoing operations |
$ |
48.2 |
|
|
$ |
10.6 |
|
|
$ |
37.6 |
|
|
22.0 |
% |
|
|
Twelve Months Ended |
|
|
|
|
|
|
|
||||||||
|
Net income reported under GAAP |
$ |
36.4 |
|
|
$ |
11.5 |
|
|
$ |
24.8 |
|
|
31.7 |
% |
|
|
Losses associated with plant shutdowns, asset impairments and restructurings |
4.1 |
|
|
0.2 |
|
|
3.8 |
|
|
|
|||||
|
(Gains) losses from sale of assets and other |
(25.9 |
) |
|
(6.4 |
) |
|
(19.5 |
) |
|
|
|||||
|
|
46.8 |
|
|
8.6 |
|
|
38.2 |
|
|
|
|||||
|
Net income (loss) from ongoing operations |
$ |
61.4 |
|
|
$ |
13.9 |
|
|
$ |
47.3 |
|
|
22.8 |
% |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200316005431/en/
neill.bellamy@tredegar.com
Source:
